Search results for "interventions"

showing 10 items of 300 documents

A Nutritional Approach to the Prevention of Cancer: from Assessment to Personalized Intervention

2016

Among lifestyle factors, nutrition is one of the most important determinants of health, and represents a pivotal element of cancer risk. Nonetheless, epidemiological evidences of the relationship between several cancers and specific foods and nutrients is still inadequate, and solid conclusions are missing. Several epidemiological studies related increased consumption of high fat diet and the risk to develop different types of cancer. Indeed, caloric restriction without malnutrition is associated to cancer prevention, due to the reduction in the activity of pro-aging pathways, of inflammation in precancerous cells, and to the increase of the apoptosis of damaged cells. Food may be also the …

Nutritional interventionsNutritional interventioncancer preventionlifestyle and cancer riskArticlesNutritional interventions cancer prevention lifestyle and cancer risk
researchProduct

A phase I dose escalation and expansion study of the next generation oral SERD AZD9833 in women with ER-positive, HER2-negative advanced breast cancer

2020

1024 Background: AZD9833 is an oral selective estrogen receptor (ER) antagonist and degrader (SERD) that has shown antitumor efficacy in a range of preclinical models of breast cancer. Methods: SERENA-1 (NCT03616587) is an ongoing Phase 1, open-label study in pre- and post-menopausal women, after ≥1 endocrine therapy and ≤2 prior chemotherapies for ER+ HER2- advanced breast cancer (ABC). The primary objective is to determine the safety and tolerability of AZD9833 once daily (QD), with dose-limiting toxicities (DLTs) in 28d defining the maximum tolerated dose. Secondary objectives include pharmacokinetics and anti-tumor response. Pharmacodynamic (PD) analysis includes ER modulation in paire…

OncologyCancer Researchmedicine.medical_specialtyAdvanced breastClinical Trials and Supportive ActivitiesEstrogen receptor32 Biomedical and Clinical Sciences6 Evaluation of treatments and therapeutic interventions03 medical and health sciences0302 clinical medicineBreast cancerClinical ResearchInternal medicineBreast CancerDose escalationMedicineCancerbusiness.industryAntagonistHER2 negativeCancermedicine.disease3211 Oncology and CarcinogenesisOncology030220 oncology & carcinogenesis6.1 Pharmaceuticalsbusiness030215 immunology
researchProduct

Associations of ofatumumab exposure and treatment outcomes in patients with untreated CLL receiving chemoimmunotherapy

2016

Relationships between patient characteristics, ofatumumab pharmacokinetics, and treatment outcomes were investigated in this phase 2 trial of ofatumumab plus fludarabine and cyclophosphamide (FC) in untreated chronic lymphocytic leukemia. Patients were randomized 1:1 to receive 500 or 1000 mg ofatumumab (Cycle 1; 300 mg) plus FC every 4 weeks for six cycles. Median C(max) and C(trough) values were similar at Cycle 1 regardless of the ultimate clinical outcome. At later doses, these values were higher for patients with complete response (CR) than for other patients. Higher C(max) and C(trough) values at Cycles 3 and 6 were significantly associated with an increased likelihood of CR, whereas …

OncologyMaleCancer ResearchLymphomaDrug ResistanceMedizinKaplan-Meier EstimatePharmacologychemistry.chemical_compound0302 clinical medicineAntineoplastic Agents ImmunologicalRecurrencehemic and lymphatic diseasesAntineoplastic Combined Chemotherapy Protocols80 and overChronicNeoplasm MetastasisLenalidomideCancerAged 80 and overUnivariate analysisLeukemiaRemission InductionAntibodies MonoclonalHematologyphase IIMiddle AgedLymphocyticThalidomideFludarabineClinical trialTreatment OutcomeOncologyTolerability6.1 Pharmaceuticals030220 oncology & carcinogenesisRetreatmentMathematikRituximabFemalePatient SafetyRefractory Chronic Lymphocytic LeukemiaUntreated Chronic Lymphocytic Leukemiamedicine.drugAdultmedicine.medical_specialtyCyclophosphamidelenalidomideClinical Trials and Supportive ActivitiesClinical SciencesImmunologyCmaxAntineoplastic AgentsNeutropeniaOfatumumabAntibodies Monoclonal HumanizedDrug Administration ScheduleArticle03 medical and health sciencesRare DiseasesClinical ResearchChemoimmunotherapyInternal medicinemedicineImmunologic FactorsAnimalsHumansIn patientAdverse effectLenalidomideAgedNeoplasm StagingChromosome Aberrationsbusiness.industryB-CellEvaluation of treatments and therapeutic interventionsmedicine.diseaseHaresLeukemia Lymphocytic Chronic B-CellDiscontinuationClinical trialchemistryDrug Resistance NeoplasmNeoplasmbusinessCLL030215 immunology
researchProduct

Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers:…

2021

PURPOSE The role of maintenance therapy for gastric (GC) or gastroesophageal junction cancer (GEJC) is unclear. We investigated avelumab (anti–programmed death ligand-1 [PD-L1]) maintenance after first-line induction chemotherapy for GC/GEJC. PATIENTS AND METHODS JAVELIN Gastric 100 was a global, open-label, phase III trial. Eligible patients had untreated, unresectable, human epidermal growth factor receptor 2–negative, locally advanced or metastatic GC or GEJC. Patients without progressive disease after 12 weeks of first-line chemotherapy with oxaliplatin plus a fluoropyrimidine were randomly assigned 1:1 to avelumab 10 mg/kg every 2 weeks or continued chemotherapy, stratified by region (…

OncologyMaleCancer Researchmedicine.medical_treatmentAvelumab0302 clinical medicineMaintenance therapyMonoclonalAntineoplastic Combined Chemotherapy Protocols030212 general & internal medicineMulticenterHumanizedCancerbiologyInduction ChemotherapyMiddle AgedPrognosisOxaliplatinSurvival RateOncology6.1 Pharmaceuticals030220 oncology & carcinogenesisFemaleFluorouracilmedicine.drugDouble-Blindmedicine.medical_specialtyFirst lineClinical Trials and Supportive ActivitiesClinical SciencesOncology and CarcinogenesisAntibodies Monoclonal HumanizedAntibodiesMaintenance Chemotherapy03 medical and health sciencesRare DiseasesClinical ResearchJavelinStomach NeoplasmsInternal medicinemedicineHumansIn patientOncology & CarcinogenesisCapecitabineAgedChemotherapybusiness.industryEvaluation of treatments and therapeutic interventionsInduction chemotherapyCancerbiology.organism_classificationmedicine.diseaseOpen-LabelTherapyCisplatinbusinessFollow-Up StudiesJournal of clinical oncology : official journal of the American Society of Clinical Oncology
researchProduct

Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study

2012

Item does not contain fulltext INTRODUCTION: A recent genome-wide association study in European systemic sclerosis (SSc) patients identified three loci (PSORS1C1, TNIP1 and RHOB) as novel genetic risk factors for the disease. The aim of this study was to replicate the previously mentioned findings in a large multicentre independent SSc cohort of Caucasian ancestry. METHODS: 4389 SSc patients and 7611 healthy controls from different European countries and the USA were included in the study. Six single nucleotide polymorphisms (SNP): rs342070, rs13021401 (RHOB), rs2233287, rs4958881, rs3792783 (TNIP1) and rs3130573 (PSORS1C1) were analysed. Overall significance was calculated by pooled analys…

Oncologymedicine.medical_specialtysystemic sclerosisRHOBImmunologyGenome-wide association studySingle-nucleotide polymorphismBioinformaticsPolymorphism Single NucleotideGeneral Biochemistry Genetics and Molecular BiologyArticleWhite PeopleRheumatologyRisk FactorsInternal medicineRhoB GTP-Binding Proteinsystemic sclerosis; genome wide screening; genetic risk factorsmedicinegenetic risk factorsImmunology and AllergySNPHumansGenetic Predisposition to DiseaseAllelerhoB GTP-Binding ProteinRheumatology and AutoimmunityScleroderma Systemicbusiness.industryHaplotypeProteinsgenome wide screeningDNA-Binding ProteinsEuropeHaplotypesCohortEvaluation of complex medical interventions Auto-immunity transplantation and immunotherapy [NCEBP 2]businessGenome-Wide Association Study
researchProduct

Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015 : a systematic analysi…

2016

BACKGROUND: Established in 2000, Millennium Development Goal 4 (MDG4) catalysed extraordinary political, financial, and social commitments to reduce under-5 mortality by two-thirds between 1990 and 2015. At the country level, the pace of progress in improving child survival has varied markedly, highlighting a crucial need to further examine potential drivers of accelerated or slowed decreases in child mortality. The Global Burden of Disease 2015 Study (GBD 2015) provides an analytical framework to comprehensively assess these trends for under-5 mortality, age-specific and cause-specific mortality among children under 5 years, and stillbirths by geography over time. METHODS: Drawing from ana…

PediatricsNutrition and DiseaseGlobal HealthCommunicable Disease0302 clinical medicineVoeding en ZiekteInfant MortalityCompensation law of mortalityGlobal healthMedicineLIFE EXPECTANCY030212 general & internal medicineDEVELOPING-COUNTRIES10. No inequalityMedicine(all)NEWBORN BABIESMedicine (all)Mortality rate1. No povertyDEATHPublic Health Global Health Social Medicine and EpidemiologyGeneral Medicine11 Medical And Health SciencesStillbirth3. Good healthChild MortalitySURVIVALCHILD-MORTALITYHEALTHLife Sciences & BiomedicineDEVELOPMENT GOAL 4HumanINTERVENTIONSmedicine.medical_specialtyRJINTEGRATED APPROACHDeveloping country610Communicable Diseasesneonatal03 medical and health sciencesMedicine General & Internal030225 pediatricsGeneral & Internal MedicineLife ScienceHumansGlobal Burden of Disease StudyVLAGEstimationScience & Technologybusiness.industryKlinisk medicinInfantGBD 2015 Child Mortality CollaboratorsInfant mortalityMalariaChild mortalityFolkhälsovetenskap global hälsa socialmedicin och epidemiologiLife expectancyClinical MedicineRGbusinessDemography
researchProduct

Distribution of maternity units and spatial access to specialised care for women delivering before 32 weeks of gestation in Europe

2010

Contains fulltext : 88841.pdf (Publisher’s version ) (Closed access) Survival and quality of life are improved for very preterm babies when delivery occurs in a maternity unit with on-site neonatal intensive care (level III unit). We investigated the impact of distance on the probability of delivering in such a unit for births before 32 weeks of gestation from 9 European regions with diverse perinatal health systems (the MOSAIC cohort). We analysed distances between women's homes, and the nearest level III in population quartiles, adjusting for maternal and pregnancy characteristics. Living farther away from a level III reduced access to specialised care everywhere; in some regions women re…

Pediatricsmedicine.medical_specialtyHealth (social science)Perinatal careGeography Planning and DevelopmentPopulation[ SHS.GEO ] Humanities and Social Sciences/Geography03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Hospital planningPregnancy030225 pediatricsIntensive caremedicineHumansMaternal Health Services030212 general & internal medicineeducationComputingMilieux_MISCELLANEOUSPregnancyeducation.field_of_study[SHS.SOCIO]Humanities and Social Sciences/SociologyDistancebusiness.industryHealth services accessibilityPublic Health Environmental and Occupational HealthInfant Newborn[ SHS.SOCIO ] Humanities and Social Sciences/Sociology[SHS.GEO]Humanities and Social Sciences/Geographymedicine.disease3. Good healthEuropeLogistic ModelsQuartileEvaluation of complex medical interventions [NCEBP 2]Premature birthdistance; europe; health services accessibility; hospital planning; perinatal careCohortMultivariate AnalysisGestationPremature BirthFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieHuman medicinebusinessDemography
researchProduct

Resultados de un programa de educación postural, con una intervención gamificada vs intervención tradicional

2021

[Resumen] La metodología de enseñanza adoptada por el profesorado puede influir en los niveles de participación y aprendizaje del alumnado. El objetivo principal de este estudio fue comparar el efecto de dos programas de intervención de educación postural en función de la metodología utilizada. Un total de 36 estudiantes (19 niñas y 17 niños) de 1º de Educación Secundaria Obligatoria participaron en el estudio. En el primer programa de intervención se aplicó una metodología gamificada, mientras que en el segundo se empleó una metodología tradicional. Ambos programas de intervención se llevaron a cabo a lo largo de 6 sesiones. Se analizaron los contenidos teóricos a través de dos cuestionari…

Physical Education (secon dary)Posturamedia_common.quotation_subjectTeaching methodApplied psychologyPosturePhysical education (secondary)Session (web analytics)03 medical and health sciences0302 clinical medicinePerceptionIntervention (counseling)030212 general & internal medicineEducación físicamedia_commonEducación para la saludMotivation030229 sport sciencesGeneral MedicineGamificationTest (assessment)GamificaciónFeelingHealth educationScale (social sciences)MotivaciónEducational interventionsPsychology
researchProduct

Redox Regulation of Metabolic Syndrome: From Biochemical Mechanisms to Nutritional Interventions.

2021

According to its “harmonized” definition, metabolic syndrome (MetS) is described as a cluster of metabolic factors that increases the risk of cardiovascular diseases, diabetes (DM) and associated morbidities such as dementia [...]

Physiologybusiness.industryClinical BiochemistryMEDLINECell BiologyRM1-950medicine.diseaseBioinformaticsDisease clusterBiochemistrymetabolic syndromeredox regulationn/aEditorialNutritional InterventionsDiabetes mellitusmental disordersmedicineDementiaTherapeutics. PharmacologyMetabolic syndromebusinessMolecular BiologyAntioxidants (Basel, Switzerland)
researchProduct

Catheter venography for the assessment of internal jugular veins and azygous vein: position statement by expert panel of the International Society fo…

2013

This document by an expert panel of the International Society for Neurovascular Disease is aimed at presenting current technique and interpretation of catheter venography of the internal jugular veins, azygous vein and other veins draining the central nervous system. Although interventionalists agree on general rules, significant differences exist in terms of details of venographic technique and interpretations of angiographic pictures. It is also suggested that debatable findings should be investigated using multimodal diagnostics. Finally, the authors recommend that any publication on chronic cerebrospinal venous insufficiency should include detailed description of venographic technique u…

Position statementmedicine.medical_specialtyCatheterization Central VenousEndovascular therapyVenographyConstriction Pathologicmultiple sclerosisRisk Assessmentneurovascular interventionsPredictive Value of TestsmedicineHumansVascular Diseasesvascular malformationsUltrasonography Interventionalmedicine.diagnostic_testbusiness.industryPhlebographyNeurovascular bundlemedicine.diseasePrognosisCerebral VeinsCatheterAzygous veinChronic cerebrospinal venous insufficiencyCerebrovascular DisordersChronic diseaseVenous InsufficiencyAzygos VeinChronic Diseasecardiovascular systemRadiologyUltrasonographyJugular VeinsCardiology and Cardiovascular MedicinebusinessVASA. Zeitschrift fur Gefasskrankheiten
researchProduct